Your session is about to expire
← Back to Search
Post-Operative Activity Restriction Duration for Stress Urinary Incontinence
N/A
Recruiting
Led By Oz Harmanli, MD
Research Sponsored by Yale University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Patients who are ambulatory and scheduled for midurethral sling placement surgery only for treatment of stress urinary incontinence
At least 18 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks, 6 months, and 1 year
Awards & highlights
Study Summary
This trial will compare outcomes and satisfaction for patients who have different post-operative restrictions following a midurethral sling procedure.
Who is the study for?
This trial is for ambulatory patients at least 18 years old who are scheduled for midurethral sling surgery to treat stress urinary incontinence. Participants must be able to understand and complete study documents in English or Spanish, and commit to not lifting heavy objects (over 20 lbs) for 6 weeks.Check my eligibility
What is being tested?
The study compares two different durations of activity restrictions after midurethral sling surgery: one group will have a 3-week restriction, while the other will have a 6-week restriction. The focus is on postoperative outcomes and patient satisfaction.See study design
What are the potential side effects?
Since this trial involves post-surgical care instructions rather than medication, it does not directly test interventions with side effects. However, general surgical risks may include discomfort, infection risk at the incision site, or complications related to reduced activity.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I can walk and am scheduled for a specific surgery to treat stress urinary incontinence.
Select...
I am 18 years old or older.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 6 weeks, 6 months, and 1 year
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks, 6 months, and 1 year
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in urogenital distress inventory (UDI) stress score
Secondary outcome measures
Activity Assessment Scale (AAS)
Change in Patient Satisfaction Post-Operative Questionnaire
Change in cough stress test
+2 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: 6-week post-operative activity restrictionExperimental Treatment1 Intervention
Participants will be given postoperative instructions which include refraining from lifting anything over 20 pounds, avoiding strenuous exercise, running, or performing high-impact aerobic activities for 6-weeks post operation.
Group II: 3-week post-operative activity restrictionExperimental Treatment1 Intervention
Participants will be given postoperative instructions which include refraining from lifting anything over 20 pounds, avoiding strenuous exercise, running, or performing high-impact aerobic activities for 3-weeks post operation.
Find a Location
Who is running the clinical trial?
Boston Scientific CorporationIndustry Sponsor
719 Previous Clinical Trials
932,865 Total Patients Enrolled
Yale UniversityLead Sponsor
1,851 Previous Clinical Trials
2,738,008 Total Patients Enrolled
Oz Harmanli, MDPrincipal InvestigatorYale University
2 Previous Clinical Trials
137 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I can walk and am scheduled for a specific surgery to treat stress urinary incontinence.I cannot read or understand English or Spanish well enough to complete study documents.I can avoid heavy lifting (20 lbs) for 6 weeks.I am 18 years old or older.I am having surgery for pelvic organ prolapse not including a midurethral sling.
Research Study Groups:
This trial has the following groups:- Group 1: 3-week post-operative activity restriction
- Group 2: 6-week post-operative activity restriction
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
What is the current participant enrollment rate for this experiment?
"Affirmative, the information on clinicaltrials.gov implies that this trial is currently searching for participants. Originally posted in July 2021 and last edited in November of the same year, it seeks to find 205 volunteers across 1 site."
Answered by AI
Is this experiment currently recruiting participants?
"Per clinical trials.gov, this medical trial is presently enrolling participants. This research was initially posted on July 1st 2021 and has since been modified as of November 1st 2021."
Answered by AI
Recent research and studies
Share this study with friends
Copy Link
Messenger